ArticleInternational urology and nephrology2022

The effect of sodium-glucose cotransporter 2 inhibitor (tofogliflozin) on renal tubular damage in diabetic patients without albuminuria.

Homare Shimohata et al.PubMed ↗Publisher ↗

No numbers read from the abstract.